Finance

Lists
Why is KOAN up 43,33%?
Dive Deeper
KOAN:OTCMKTS
Apollo Biowellness Inc
USD 0,00043
+43,33%
(+0,00013) 1D
16 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KOAN...
Open
USD 0,00
High
USD 0,00
Low
USD 0,00
Mkt. cap
57,25 k
Avg. vol.
2,60 m
Volume
25,97 m
52-wk high
USD 0,02
52-wk low
USD 0,00
Beta
0,01
Shares outstanding
195,25 m
No. of employees
6
Open
USD 0,00
High
USD 0,00
Low
USD 0,00
Mkt. cap
57,25 k
Avg. vol.
2,60 m
Volume
25,97 m
52-wk high
USD 0,02
52-wk low
USD 0,00
Beta
0,01
Shares outstanding
195,25 m
No. of employees
6
News stories
From web sources and news partners
About Apollo Biowellness Inc
CEO-
Employees6
Founded2010
HeadquartersCalabasas, Kalifornië, Verenigde State van Amerika
SectorPharmaceutical industry
Websiteapollobiowellness.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2024
Des. 2024
Mrt. 2025
Revenue
598,63 k
546,31 k
430,77 k
Cost of goods sold
179,16 k
182,94 k
140,72 k
Cost of revenue
179,16 k
182,94 k
140,72 k
Research and development expenses
3,51 k
-
-
Total research and development expenses
-
-
-
Selling, general, and admin expenses
685,72 k
714,03 k
620,28 k
Operating expense
689,23 k
714,03 k
620,28 k
Total operating expenses
868,38 k
896,97 k
761,01 k
Operating income
-269,76 k
-350,66 k
-330,24 k
Other non operating income
-
3,37 k
215,00
EBT including unusual items
-305,50 k
-577,44 k
-411,82 k
EBT excluding unusual items
-273,04 k
-577,44 k
-411,82 k
Income tax expense
-
-
-
Effective tax rate
-
-
-
Other operating expenses
-
-
-
Net income
-305,50 k
-577,44 k
-411,82 k
Net profit margin
-51,03%
-105,70%
-95,60%
Earnings per share
-
-
-
Interest and investment income
-
-
-
Interest expense
-3,28 k
-230,15 k
-81,79 k
Net interest expenses
-3,28 k
-230,15 k
-81,79 k
Depreciation and amortization charges
-
-
-
EBITDA
-269,76 k
-350,66 k
-325,96 k
Gain or loss from assets sale
69,24 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme